|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Nabriva Therapeutics (NASDAQ: NBRV) through any online brokerage.
There are no as such competitors for Nabriva Therapeutics.
The latest price target for Nabriva Therapeutics (NASDAQ: NBRV) was reported by Morgan Stanley on December 7, 2020. The analyst firm set a price target for 20.00 expecting NBRV to rise to within 12 months (a possible 1654.39% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Nabriva Therapeutics (NASDAQ: NBRV) is $1.14 last updated Tue Oct 26 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Nabriva Therapeutics.
Nabriva Therapeutics’s $Q3 earnings are confirmed for after-market on $November 9, 2021.
There is no upcoming split for Nabriva Therapeutics.
Nabriva Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.